The world continues to feel the ripple effects of the COVID-19 pandemic, even into 2025. While vaccines, therapeutics, and preventive measures have significantly reduced the global burden of the disease, the healthcare industry is still adapting to the disruptions and…
Clinical trials are undergoing a paradigm shift from a site-centric or traditional approach wherein the patients are required to go to central sites for consent processes, assessments, and safety monitoring to a ‘decentralized’ or ‘hybrid’ approach in which some or…
Although the United States Food and Drug Administration (FDA) has always supported and advocated the idea of decentralized trials, the real adoption and application of decentralized aspects in trials has exponentially increased in the recent years due to travel restrictions,…
Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.
ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.